ISIN<= /tr>

Ge= neral information about company
Scrip cod= e	524572
NSE Symbol	NOTLISTED<= /td>
MSEI Symbol	NOTLISTED
INE117D01018
Name of= the company	Pharmaids Pharmaceuticals Limited
Whether company is SME	No
Cla= ss of Security	Equity Shares
Type of r= eport	Quarterly
Quarter Ended / Half y= ear ended/Date of Report (For Prelisting / Allotment)	31-12-2025
Date of allotment / extinguishment (in case Capi= tal Restructuring selected) / Listing Date
Shareholding pattern filed under	Regulation 31 (1) (b)
Whether the listed entity is Public Sector Undertak= ing (PSU)?	No

<= td class=3D"l">2

Declaration
Sr. No.	Particular	Yes/No	Promoter and Promoter = Group	Public shareholder	Non Promoter- Non Public
1	Whether the Listed Entity has issued any partly p= aid up shares?	No	No	No	No
Whether the Listed Entity has issued a= ny Convertible Securities ?	No	No	No	No
3	Whether the Listed Entity= has issued any Warrants ?	No	No	No	No
4	Whether Listed Entity has = granted any ESOPs, which are outstanding?	No	No	No=	No
5	Whether the= Listed Entity has any shares against which depository receipts are issued?=	No	No	No	No
6	Whether the Listed Entity has any shares in locked-i= n?	No	No	No	No
7	Whether any shares held by promoters are encumbere= d under "Pledged"?	No	No
8	Whether any shares hel= d by promoters are encumbered under "Non-Disposal Undertaking"?	No<= /td>	No
9	Whether any shares held by promoters are encumbered,= other than by way of Pledge or NDU, if any?	No	No
10	Whether company has equity shares with differential voting rights?	No	No	No	No
1= 1	Whether the listed entity has any significant benefic= ial owner?	Yes

<= tr>

Table VI - Statement showing foreign ownersh= ip limits
Particular	Approved lim= its (%)	Limits utilized (%)
As on shareholding date	74	0.5
As on the end of previous 1st quarter	74	0.79
As on the end of previous 2nd quarter	74	0.75
As on the end of previous 3rd quarter	74	0.77
= As on the end of previous 4th quarter	= 74	0.68

<= br>Promoter & Promoter Group11634519= = 23633293Shares held by Employee Trusts<= td class=3D"l f">3526781235267812

Table I - Summary Statement holding of = specified securities

Cate= gory (I)

Category of shareholder (II)

Nos. Of shareholders (III)

No. of fully paid up equity share= s held (IV)

No. Of Partly paid-up equity share= s held (V)

No. Of shares underlying Depository= Receipts (VI)

Total nos. shares held (VII) =3D (IV)+(V)+ (VI)

Shareholding a= s a % of total no. of shares (calculated as per SCRR, 1957) (VIII) As a % of (A+B+C2)

Number of Voting Rig= hts held in each class of securities (IX)

No. Of Shares Underlying Outstandi= ng convertible securities (XA)

No. of Shares Underlying Outstandi= ng Warrants=20 (XB)

No. Of Outstanding ESOP Granted (X= C)

No. of Shares Underlying Outstanding= convertible securities, No. of Warrants and ESOP etc. (X) =3D (XA+XB+XC)

Total No. of shares = on fully diluted basis (including warrants, ESOP, Convertible Securities et= c.) (XI)=3D(VII+X)

No of Votin= g (XIV) Rights

Total as a % of (A+B+C)

Class eg:X

Class eg:Y

Total

(A)

11634519

32.99

11634519

32.99

11634519

(B)

Public

23633293

67.01

23633= 293

67.01

2363= 3293

(C)

Non Promoter-= Non Public

<= /td>

(C1)

Shares underlying DRs

(C2)

<= /td>

Tota= l

8288

35267812

100

35267812

100

= = = =

Table I - Summary Statement holding of specified securities

Category (I)

Category of shareholder (II)

Shareholding , as a % assuming full = conversion of convertible securities ( as a percentage of diluted share cap= ital) (XII)=3D (VII)+(X) As a % of (A+B+C2)

Number of Locked in sh= ares (XIII)

Number of Shares pledged (XIV)

Non-Disposal Undertaking (XV)

Other encumbrances, if any (XVI)

Total Number of Shares encumbered= =20 (XVII) =3D (XIV+XV+XVI)

Number of equity = shares held in dematerialized form=20 (XVIII)

Sub-categorization of shares

No. (a)